Skip to content
healthcare.dev

PYRUKYND

NDC 71334-215, mitapivat, tablet, film coated, from Agios Pharmaceuticals, Inc..

Product NDC
71334-215
Status
Listed
Labeler
Agios Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216196
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71334-215 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MITAPIVAT50 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; P-Glycoprotein Inhibitors [MoA]; Pyruvate Kinase Activator [EPC]; Pyruvate Kinase Activators [MoA]; UGT1A1 Inducers [MoA]

Package NDCNDC-11Package
71334-215-50713340215504 BLISTER PACK in 1 CARTON (71334-215-50) / 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-215-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4ccee896-e313-4c6c-9674-b4746ada0a90

Use it

Look up 71334-215 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71334-215 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71334-215. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.